No record found.

Startup

Excelsior Sciences raises $95 million for drug discovery with AI-ready chemistry

Excelsior Sciences raises $95 million for drug discovery with AI-ready chemistry

EIB, Angelini Ventures team up to pump €150 million into European biotech, digital health startups

EIB, Angelini Ventures team up to pump €150 million into European biotech, digital health startups

Teva launches 'Teva Rise' to harness global innovation and transform healthcare

Teva launches 'Teva Rise' to harness global innovation and transform healthcare

Digitization

Grace and Molecule.one strike multi-year AI pact to break peptide manufacturing bottlenecks

Avandra Health acquires DatCard and Sorna to build industry-leading medical imaging platform

Avandra Health acquires DatCard and Sorna to build industry-leading medical imaging platform

L&T Technology unveils next-gen AI digital twin for lung diagnostics

L&T Technology unveils next-gen AI digital twin for lung diagnostics

Latest Stories

Caplin Point Laboratories’ injectables facility completes INVIMA audit successfully

Thermo Fisher Scientific appoints Anoopa Menon as Director

Novartis appoints Vrinda Taneja as Director – People & Organisation, International India

Emcure Pharmaceuticals appoints Barnona Basu as Director – Marketing (India)

Biocon Biologics signs settlement and lcense agreement to commercialize biosimilar Aflibercept

Opinion

Metal-free catalysis is transforming future of sustainable pharmaceutical innovation

Metal-free catalysis is transforming future of sustainable pharmaceutical innovation

From Policy to Practice: How India’s Pharmaceutical Industry is Being Shaped by the PLI Scheme – by Vikram Aditya Sehgal, Director – Finance, Centrient India

From Policy to Practice: How India’s Pharmaceutical Industry is Being Shaped by the PLI Scheme – by Vikram Aditya Sehgal, Director – Finance, Centrient India

Interviews

Only 4-5 Indian pharma companies have a strong presence in Russia, opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group

Only 4-5 Indian pharma companies have a strong presence in Russia, opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group

Only 4-5 Indian pharma companies have a strong presence in Russia but the opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group

Only 4-5 Indian pharma companies have a strong presence in Russia but the opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group

Companies must shift from L1 costing to Life Cycle Cost Analysis: Abhilash Pasham, Associate GM - Central Engineering & Projects, Dr. Reddy's Laboratories

Companies must shift from L1 costing to Life Cycle Cost Analysis: Abhilash Pasham, Associate GM - Central Engineering & Projects, Dr. Reddy's Laboratories

Packaging